Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection

• Published in: Fertility and sterility Vol. 87; no. 1; pp. 223 - 226
• Main Authors: Smeenk, Jesper M.J., M.D, Sweep, Fred C.G.J., Ph.D, Zielhuis, Gerhard A., Ph.D, Kremer, Jan A.M., Ph.D, Thomas, Chris M.G., Ph.D, Braat, Didi D.M., Ph.D
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 2007; Elsevier Science
• Subjects: Adult; Anti-Mullerian Hormone; Biological and medical sciences; Biomarkers - blood; Female; Fertilization in Vitro - methods; Glycoproteins - blood; Gynecology. Andrology. Obstetrics; Humans; Infertility, Female - blood; Infertility, Female - diagnosis; Infertility, Female - therapy; Internal Medicine; Medical sciences; Obstetrics and Gynecology; Ovulation Induction; Pregnancy; Pregnancy Outcome; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Sperm Injections, Intracytoplasmic - methods; Testicular Hormones - blood; Treatment Outcome; In vitro fertilization embryo transfer; Pregnancy; Antimüllerian hormone; Embryo; Fertility; Semen; Quality; Assisted procreation; Female; Injection; Predictive factor; Ovarian hormone
• ISSN: 0015-0282; 1556-5653
• DOI: 10.1016/j.fertnstert.2006.06.019

Antimüllerian hormone (AMH) and other markers of ovarian reserve were assessed to determine their predictive value with respect to treatment outcome. In a multivariate regression analysis, AMH was found to be predictive of the number of oocytes and the number of embryos, but not of embryo quality or the chance of a pregnancy, after IVF/ICSI.